Showing 1 to 1 of 1 results
forbes.com
🌐 85% Global Worthiness
Johnson & Johnson Targets Autoimmune Diseases with Novel Therapies
Johnson & Johnson, a leader in immunology, is researching treatments for over 80 autoimmune and alloantibody diseases affecting nearly 240 million globally, focusing on three segments with a targeted approach to lower pathogenic IgG antibodies while preserving overall immune function, addressing a c...
Johnson & Johnson Targets Autoimmune Diseases with Novel Therapies
Johnson & Johnson, a leader in immunology, is researching treatments for over 80 autoimmune and alloantibody diseases affecting nearly 240 million globally, focusing on three segments with a targeted approach to lower pathogenic IgG antibodies while preserving overall immune function, addressing a c...
Progress
36% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results